OncoSpear ApS

CVR 42093734 · Private limited company (ApS) · Active · Medium risk

OncoSpear ApS is a Private limited company (ApS), founded on , based in Hinnerup. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. 5 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 570k and a net result of DKK -822k. CEO: Niels Jonas Heilskov Graversen, Geert Gilbert Tackaert.

Bankruptcy risk for OncoSpear ApS

2.0%
probability of bankruptcy within 12 months
Medium risk

1.4 × the average (1.41%) · higher risk than 82% of active Danish companies

Lowest riskHighest risk

Increases the risk

Moves in the last 2 years2 · bankruptcy rate 23.9%2.7×
Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
CEO changes1 · bankruptcy rate 11.4%1.3×
Loss for the yearYes · bankruptcy rate 10.3%1.2×
Equity ratio0%–10% · bankruptcy rate 10.2%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Auditor's statementExtended review · bankruptcy rate 2.9%0.33×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
42093734
Status
Active
Company type
Private limited company (ApS)
Founded
(5 years)
Address
c/o Anders Etzerodt, Lucernevej 2
8382 Hinnerup
Municipality
Favrskov
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 109k
Auditor
KOVSTED & SKOVGÅRD, REVISION & RÅDGIVNING, STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late0 of 5
Missing annual reportNo
Negative equityNo
Equity ratio6.0%
Current ratio1,196%
Moves (last 2 years)2
CEO changes in total1
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyYes

Financials and key figures

Financial year20252024
Gross profitDKK 2.9mDKK -4.7m
Net profitDKK -822kDKK -6.5m
EquityDKK 570kDKK 1.4m
Total assetsDKK 9.5mDKK 3.3m
CashDKK 2.5m–
Short-term debtDKK 796k–
Avg. employees5–

Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Kovsted &amp; Skovgård, Statsautoriseret revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025181
1 Jan 2024 – 31 Dec 2024164
1 Jan 2023 – 31 Dec 2023179
1 Jan 2022 – 31 Dec 2022180
1 Feb 2021 – 31 Dec 2021151

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEONiels Jonas Heilskov GraversenCurrent
CEOGeert Gilbert TackaertCurrent
BoardJens Kristian Damsgaard
BoardSøren Kragh Moestrup
BoardHolger Jon Møller
BoardAnders Etzerodt
BoardToby Lawrence
BoardAlexander Bharmal Demoulin
BoardDebora Catharina Dumont
BoardSøren Kragh Moestrup
BoardDebora Catharina Dumont
Owner (100%)SPICA THERAPEUTICSCurrent
Owner (15%)MOESTRUP HOLDING 2007 ApS
Owner (15%)MØLLER HOLDING 2007 ApS
Owner (15%)PHIDEAS ApS
Owner (25%)DeLiver Pharma ApS
Owner (15%)Etze Holding ApS
Owner (15%)Toby Lawrence
Owner (10%)MOESTRUP HOLDING 2007 ApS
Owner (10%)MØLLER HOLDING 2007 ApS
Owner (10%)PHIDEAS ApS
Owner (10%)DeLiver Pharma ApS
Owner (5%)Etze Holding ApS
Owner (5%)Toby Lawrence
Owner (33%)Bioqube Factory Fund I CommV
Owner (5%)MOESTRUP HOLDING 2007 ApS
Owner (5%)MØLLER HOLDING 2007 ApS
Owner (5%)PHIDEAS ApS
Owner (50%)Bioqube Factory Fund I CommV
AuditorKOVSTED & SKOVGÅRD, REVISION & RÅDGIVNING, STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderMOESTRUP HOLDING 2007 ApSCurrent
FounderMØLLER HOLDING 2007 ApSCurrent
FounderPHIDEAS ApSCurrent
FounderDeLiver Pharma ApSCurrent
FounderEtze Holding ApSCurrent
FounderToby LawrenceCurrent

The CEOs' other companies

Niels Jonas Heilskov Graversen – 5 other companies

Address history (2 moves)

c/o Anders Etzerodt, Lucernevej 2, 8382 Hinnerup
c/o Jonas Graversen, Sanatorievej 8, 5600 Faaborg
Tesdorpfsvej 12, 5000 Odense C

Other companies at the same address

Similar companies in Favrskov

Questions and answers about OncoSpear ApS

Has OncoSpear ApS gone bankrupt?

No, OncoSpear ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of OncoSpear ApS?

Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.

Who is the CEO of OncoSpear ApS?

Niels Jonas Heilskov Graversen, Geert Gilbert Tackaert are the CEOs of OncoSpear ApS.

Who is the auditor of OncoSpear ApS?

OncoSpear ApS most recently used KOVSTED & SKOVGÅRD, REVISION & RÅDGIVNING, STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was OncoSpear ApS founded?

OncoSpear ApS was founded on 1 February 2021.

What is the equity of OncoSpear ApS?

Equity was DKK 570k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.